Cargando…
Tumor microenvironment responsive drug delivery systems
Conventional tumor-targeted drug delivery systems (DDSs) face challenges, such as unsatisfied systemic circulation, low targeting efficiency, poor tumoral penetration, and uncontrolled drug release. Recently, tumor cellular molecules-triggered DDSs have aroused great interests in addressing such dil...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486519/ https://www.ncbi.nlm.nih.gov/pubmed/32952667 http://dx.doi.org/10.1016/j.ajps.2019.08.003 |
_version_ | 1783581347940401152 |
---|---|
author | He, Qunye Chen, Jun Yan, Jianhua Cai, Shundong Xiong, Hongjie Liu, Yanfei Peng, Dongming Mo, Miao Liu, Zhenbao |
author_facet | He, Qunye Chen, Jun Yan, Jianhua Cai, Shundong Xiong, Hongjie Liu, Yanfei Peng, Dongming Mo, Miao Liu, Zhenbao |
author_sort | He, Qunye |
collection | PubMed |
description | Conventional tumor-targeted drug delivery systems (DDSs) face challenges, such as unsatisfied systemic circulation, low targeting efficiency, poor tumoral penetration, and uncontrolled drug release. Recently, tumor cellular molecules-triggered DDSs have aroused great interests in addressing such dilemmas. With the introduction of several additional functionalities, the properties of these smart DDSs including size, surface charge and ligand exposure can response to different tumor microenvironments for a more efficient tumor targeting, and eventually achieve desired drug release for an optimized therapeutic efficiency. This review highlights the recent research progresses on smart tumor environment responsive drug delivery systems for targeted drug delivery. Dynamic targeting strategies and functional moieties sensitive to a variety of tumor cellular stimuli, including pH, glutathione, adenosine-triphosphate, reactive oxygen species, enzyme and inflammatory factors are summarized. Special emphasis of this review is placed on their responsive mechanisms, drug loading models, drawbacks and merits. Several typical multi-stimuli responsive DDSs are listed. And the main challenges and potential future development are discussed. |
format | Online Article Text |
id | pubmed-7486519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Shenyang Pharmaceutical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-74865192020-09-18 Tumor microenvironment responsive drug delivery systems He, Qunye Chen, Jun Yan, Jianhua Cai, Shundong Xiong, Hongjie Liu, Yanfei Peng, Dongming Mo, Miao Liu, Zhenbao Asian J Pharm Sci Review Conventional tumor-targeted drug delivery systems (DDSs) face challenges, such as unsatisfied systemic circulation, low targeting efficiency, poor tumoral penetration, and uncontrolled drug release. Recently, tumor cellular molecules-triggered DDSs have aroused great interests in addressing such dilemmas. With the introduction of several additional functionalities, the properties of these smart DDSs including size, surface charge and ligand exposure can response to different tumor microenvironments for a more efficient tumor targeting, and eventually achieve desired drug release for an optimized therapeutic efficiency. This review highlights the recent research progresses on smart tumor environment responsive drug delivery systems for targeted drug delivery. Dynamic targeting strategies and functional moieties sensitive to a variety of tumor cellular stimuli, including pH, glutathione, adenosine-triphosphate, reactive oxygen species, enzyme and inflammatory factors are summarized. Special emphasis of this review is placed on their responsive mechanisms, drug loading models, drawbacks and merits. Several typical multi-stimuli responsive DDSs are listed. And the main challenges and potential future development are discussed. Shenyang Pharmaceutical University 2020-07 2019-09-26 /pmc/articles/PMC7486519/ /pubmed/32952667 http://dx.doi.org/10.1016/j.ajps.2019.08.003 Text en © 2019 Shenyang Pharmaceutical University. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review He, Qunye Chen, Jun Yan, Jianhua Cai, Shundong Xiong, Hongjie Liu, Yanfei Peng, Dongming Mo, Miao Liu, Zhenbao Tumor microenvironment responsive drug delivery systems |
title | Tumor microenvironment responsive drug delivery systems |
title_full | Tumor microenvironment responsive drug delivery systems |
title_fullStr | Tumor microenvironment responsive drug delivery systems |
title_full_unstemmed | Tumor microenvironment responsive drug delivery systems |
title_short | Tumor microenvironment responsive drug delivery systems |
title_sort | tumor microenvironment responsive drug delivery systems |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486519/ https://www.ncbi.nlm.nih.gov/pubmed/32952667 http://dx.doi.org/10.1016/j.ajps.2019.08.003 |
work_keys_str_mv | AT hequnye tumormicroenvironmentresponsivedrugdeliverysystems AT chenjun tumormicroenvironmentresponsivedrugdeliverysystems AT yanjianhua tumormicroenvironmentresponsivedrugdeliverysystems AT caishundong tumormicroenvironmentresponsivedrugdeliverysystems AT xionghongjie tumormicroenvironmentresponsivedrugdeliverysystems AT liuyanfei tumormicroenvironmentresponsivedrugdeliverysystems AT pengdongming tumormicroenvironmentresponsivedrugdeliverysystems AT momiao tumormicroenvironmentresponsivedrugdeliverysystems AT liuzhenbao tumormicroenvironmentresponsivedrugdeliverysystems |